PYXS
Pyxis Oncology, Inc.
$2.46
-0.17 (-6.46%)
At close · Jul 6
Market Cap
$187.22M
Shares
63,355,482
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Program Authorized
2,735,315 shares
as of 2022-09-30
· not restated in filings since 2022-11-01
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-11-26 | $150,000,000 | $150,000,000 | 2026-03-31 | — | 10-Q , filed 2026-05-14 |